Bakken J S
Department of Clinical Sciences, University of Minnesota, Duluth.
Nord Med. 1990;105(12):328-30.
Home intravenous antibiotic therapy (HIVAT) is increasingly employed for the treatment of chronic infections in the USA. HIVAT has been shown to be safe and effective, and is clearly cost effective for patients, hospitals and society when compared with equivalent therapy rendered in a hospital. Health care, as currently delivered in the Nordic countries, should be well suited for the adaptation of HIVAT. It is anticipated that HIVAT could bring about a substantial reduction in the expenses associated with antibiotic treatment in the Nordic countries.
在美国,家庭静脉抗生素治疗(HIVAT)越来越多地用于慢性感染的治疗。HIVAT已被证明是安全有效的,并且与在医院进行的等效治疗相比,对患者、医院和社会而言显然具有成本效益。北欧国家目前提供的医疗保健应该非常适合采用HIVAT。预计HIVAT可以大幅降低北欧国家抗生素治疗相关的费用。